Literature DB >> 25006737

Multitarget stool DNA testing for colorectal-cancer screening.

Hermann Brenner, Simone Werner, Hongda Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25006737     DOI： 10.1056/NEJMc1405215

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Diagnostics and Epidemiology of Colorectal Cancer.

Authors:  Frank T Kolligs
Journal:  Visc Med       Date:  2016-06-16

2.  Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

Authors:  Giuseppe S Sica; Cristina Fiorani; Carmine Stolfi; Giovanni Monteleone; Eleonora Candi; Ivano Amelio; Valeria Catani; Simone Sibio; Andrea Divizia; Giorgia Tema; Edoardo Iaculli; Achille L Gaspari
Journal:  Oncotarget       Date:  2015-05-30

3.  Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population.

Authors:  Hermann Brenner; Hongda Chen
Journal:  Clin Epidemiol       Date:  2017-07-13       Impact factor: 4.790

4.  MicroRNA-325-3p contributes to colorectal carcinoma by targeting cytokeratin 18.

Authors:  Chuanfang Song; Xiujie Wang; Xinxin Zhao; Jiang Ai; Yixuan Qi; Aidong Chen
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

Review 5.  Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers?

Authors:  Hélder Almeida-Lousada; André Mestre; Sara Ramalhete; Aryeh J Price; Ramon Andrade de Mello; Ana D Marreiros; Ricardo Pires das Neves; Pedro Castelo-Branco
Journal:  Curr Oncol       Date:  2021-11-20       Impact factor: 3.677

6.  Comment on "Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population".

Authors:  David A Ahlquist
Journal:  Clin Epidemiol       Date:  2017-08-28       Impact factor: 4.790

Review 7.  The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention.

Authors:  Hermann Brenner; Chen Chen
Journal:  Br J Cancer       Date:  2018-10-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.